1. From the Marriott Heart Disease Research Program, Division of Cardiovascular Diseases, Departments of Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics (A.M.F., T.J.N., S.Y., S.R., A.E.A., C.P.T., A.T.), the Department of Physical Medicine and Rehabilitation (C.P.T.), and the Department of Molecular Medicine (Y.I.), Mayo Clinic, Rochester, Minn.